Candriam S.C.A. Has $38.15 Million Stake in Tenet Healthcare Corporation $THC

Candriam S.C.A. boosted its holdings in Tenet Healthcare Corporation (NYSE:THC) by 13.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 202,158 shares of the company’s stock after purchasing an additional 23,557 shares during the period. Candriam S.C.A.’s holdings in Tenet Healthcare were worth $38,149,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Wedmont Private Capital grew its holdings in shares of Tenet Healthcare by 2.5% in the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after acquiring an additional 50 shares in the last quarter. Baron Wealth Management LLC boosted its position in Tenet Healthcare by 4.8% during the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock valued at $227,000 after purchasing an additional 52 shares during the last quarter. Sagespring Wealth Partners LLC grew its stake in Tenet Healthcare by 3.6% in the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after purchasing an additional 55 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Tenet Healthcare by 0.7% during the 4th quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after purchasing an additional 58 shares during the last quarter. Finally, Syon Capital LLC raised its stake in shares of Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after purchasing an additional 63 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

NYSE:THC opened at $204.39 on Friday. The company has a market cap of $17.61 billion, a P/E ratio of 10.63, a P/E/G ratio of 1.70 and a beta of 1.27. The firm’s fifty day moving average price is $183.90 and its two-hundred day moving average price is $197.68. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter last year, the company posted $4.36 EPS. Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Guggenheim lowered their target price on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Wall Street Zen cut shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Stephens lowered their price objective on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Wells Fargo & Company dropped their target price on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, Royal Bank Of Canada reduced their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $244.42.

Insider Buying and Selling

In related news, Director Nadja West sold 3,000 shares of the business’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.